BLS
BLS Pharmaceuticals Ltd
- Announcements, last 12 months
- 28
- Price sensitive, last 12 months
- 10
- Followed on InvestorPA
- Moderate (top 13% of companies)
Latest announcements
Sign in to see all BLS announcements.
Guidance history
| 21 Oct 2026 | FY27 revenue guidance reaffirmed at $105m to $115m, adjusted EBITDA margin 23% to 26% | |
| 15 Oct 2026 | FY27 revenue guidance of $105 million to $115 million and adjusted EBITDA margin of 23% to 26% | |
| 15 Oct 2026 | FY27 revenue guidance: $105 million to $115 million, adjusted EBITDA margin: 23% to 26% |
Sign in to see the full guidance history.
Most followed in Consumer Staples
Follow BLS to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in